New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.

Aprea Therapeutics, Inc. (Nasdaq: APRE) has entered into a Material Transfer Agreement (MTA) with MD Anderson Cancer Center ...

Metastatic prostate cancer patients in the Capital Region now have a new treatment option at Ochsner MD Anderson Cancer ...

Texas lawmakers are proposing to plow $3 billion in a new state fund for dementia research, an effort they hope will bolster efforts at dozens of medical institutions and cement the state as a ...

Aprea Therapeutics (APRE) has entered into a Material Transfer Agreement with MD Anderson Cancer Center. Under the agreement, Aprea will supply ...

Aprea Therapeutics Inc. has entered into a material transfer agreement with MD Anderson Cancer Center that will support investigation of APR-1051 as a potential treatment for head and neck squamous ...

MD Anderson Cancer Center at Cooper opened a state-of-the-art radiation oncology suite at the Cooper University Health Care ...

MD Anderson says the collaborative, set to begin in 2026, will combine the two institutions’ patient populations to “increase pediatric cancer clinical trials.” ...

Beyond documentation, healthcare technology company Baxter announced a wearable badge for nurses on Tuesday called Voalte ...

The University of Texas MD Anderson Cancer Center today announced a $9 million gift from the F. W. Bert and Mae Dean Wheeler Foundation to establish the F. W. Bert and Mae Dean Wheeler Nurse ...

Houston-based University of Texas MD Anderson Cancer Center will establish a nursing leadership academy as part of the center's Meyers Institute for Oncology Nursing with a $9 million gift from the ...